MVP ID: G0055
Most applicable medical specialty(s):
Cardiology, Internal Medicine, Family Medicine
The Advancing Care for Heart Disease MVP focuses on the clinical theme of providing fundamental treatment and management of costly clinical conditions that contribute to, or may result from, heart disease.
Quality
Report 4 quality measures (one must be an outcome or a high priority measure):
- Quality ID: 005 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
- Quality ID: 006 - Coronary Artery Disease (CAD): Antiplatelet Therapy
- Quality ID: 007 - Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
- Quality ID: 008 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
- Quality ID: 047 - Advance Care Plan
- Quality ID: 118 - Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
- Quality ID: 128 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
- Quality ID: 134 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan
- Quality ID: 238 - Use of High-Risk Medications in Older Adults
- Quality ID: 243 - Cardiac Rehabilitation Patient Referral from an Outpatient Setting
- Quality ID: 326 - Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy
- Quality ID: 377 - Functional Status Assessments for Heart Failure
- Quality ID: 392 - Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation
- Quality ID: 393 - Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision
- Quality ID: 441 - Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)
- Quality ID: 487 - Screening for Social Drivers of Health
- Quality ID: 503 - Gains in Patient Activation Measure (PAM) Scores at 12 Months
- Quality ID: 492 - Risk-Standardized Acute Cardiovascular-Related Hospital Admission Rates for Patients with Heart Failure under the Merit-based Incentive Payment System
Improvement Activities
Report Two medium-weighted improvement activities or One high- weighted improvement activity:
- Activity ID: IA_AHE_12 - Practice Improvements that Engage Community Resources to Address Drivers of Health
- Activity ID: IA_AHE_9 - Implement Food Insecurity and Nutrition Risk Identification and Treatment Protocols
- Activity ID: IA_BE_12 - Use evidence-based decision aids to support shared decision-making.
- Activity ID: IA_BE_15 - Engagement of Patients, Family, and Caregivers in Developing a Plan of Care
- Activity ID: IA_BE_24 - Financial Navigation Program
- Activity ID: IA_BE_25 - Drug Cost Transparency
- Activity ID: IA_BE_6 - Regularly Assess Patient Experience of Care and Follow Up on Findings
- Activity ID: IA_CC_9 - Implementation of practices/processes for developing regular individual care plans
- Activity ID: IA_MVP - Practice-Wide Quality Improvement in MIPS Value Pathways
- Activity ID: IA_PCMH - Electronic submission of Patient Centered Medical Home accreditation
- Activity ID: IA_PM_13 - Chronic Care and Preventative Care Management for Empaneled Patients
- Activity ID: IA_PM_14 - Implementation of methodologies for improvements in longitudinal care management for high risk patients
- Activity ID: IA_PSPA_4 - Administration of the AHRQ Survey of Patient Safety Culture
- Activity ID: IA_PSPA_7 - Use of QCDR data for ongoing practice assessment and improvements
Cost
Calculated by CMS using administrative claims data:
- Measure ID: COST_EOPCI_1 - Elective Outpatient Percutaneous Coronary Intervention (PCI)
- Measure ID: COST_HF_1 - Heart Failure
- Measure ID: COST_STEMI_1 - ST-Elevation Myocardial Infarction (STEMI) with Percutaneous Coronary Intervention (PCI)
- Measure ID: MSPB_1 - Medicare Spending Per Beneficiary (MSPB) Clinician
- Measure ID: TPCC_1 - Total Per Capita Cost (TPCC)
Population Health Measures
Select one population health measure to be scored by CMS using administrative claims data:
- #479: Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for the Merit-Based Incentive Payment Program (MIPS) Groups (Administrative Claims)(!!)
- #484: Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (Administrative Claims) (!!)
Promoting Interoperability
Report on the same PI measures required under traditional MIPS unless qualified for automatic reweighting or approved hardship exception:
- Prevention of Information Blocking
- e-Prescribing
- Query of the Prescription Drug Monitoring Program (PDMP) (Optional)
- Provide Patients Electronic Access to Their Health Information
- Support Electronic Referral Loops By Sending Health Information AND
- Support Electronic Referral Loops By Receiving and Reconciling Health Information OR
- Health Information Exchange (HIE) Bi-Directional Exchange
- Enabling Exchange Under the Trusted Exchange Framework and Common Agreement (TEFCA)
- Immunization Registry Reporting
- Syndromic Surveillance Reporting
- Electronic Case Reporting
- Public Health Registry Reporting
- Clinical Data Registry Reporting
- Security Risk Analysis
- Safety Assurance Factors for EHR Resilience Guide (SAFER Guide)
- ONC Direct Review
MVP Registration
- MVP Participants must register between April 1 – December 2, 2024 to report an MVP in 2024.
- To register, MVP Participants must select:
- The MVP they intend to report.
- 1 population health measure included in the MVP.
- Any outcomes-based administrative claims measures on which the MVP Participant intends to be scored (if available).
- If reporting as a subgroup, registration must also include:
- A list of Taxpayer Identification Numbers (TINs)/National Provider Identifiers (NPIs) in the subgroup;
- A plain language name for the subgroup (which will be used for public reporting);
- A description of the composition of the subgroup, which may be selected from a list or described in a narrative.
- MVP Participants won’t be able to:
- Submit/make changes to the MVP they select after the close of the registration period (December 2, 2024).
- Report on an MVP they didn’t register for during the 2024 performance year.
- Report on more than one MVP.